Top S&P500 movers in Tuesday's session
By Mill Chart
Last update: Nov 29, 2022
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Today's top gainers
| Ticker | Change | Comment |
|---|---|---|
| RL | 4.68% | RALPH LAUREN CORP's (NYSE:RL) shares rose 4.68% to $113.0 during Tuesday's session. |
| CE | 4.14% | CELANESE CORP's (NYSE:CE) stock price is advancing with 4.14% to a price of $104.94. In the last 6 months the stock lost 35.75%. |
| KMX | 3.78% | CARMAX INC's (NYSE:KMX) stock price is advancing with 3.78% to a price of $68.04. Shareholders saw the stock price going 25.13% lower in the past 3 months. |
| CTLT | 3.49% | CATALENT INC's (NYSE:CTLT) stock price increased by 3.49% to $48.56. In the last month the stock lost 29.1%. |
| HAL | 3.46% | HALLIBURTON CO's (NYSE:HAL) shares rose 3.46% to $37.12. A press release (Halliburton Installs First Downhole Electro-Hydraulic Wet-Connect in Deepwater Brazil) was released earlier today. |
| ALB | 2.94% | ALBEMARLE CORP's (NYSE:ALB) shares rose 2.94% to $273.94 during Tuesday's session. |
| WYNN | 2.94% | WYNN RESORTS LTD's (NASDAQ:WYNN) shares rose 2.94% to $80.5 during Tuesday's session. The stock is trading 34.13% higher than a month ago. |
| APA | 2.87% | APA CORP's (NASDAQ:APA) stock price increased by 2.87% to $46.25. Yesterday the company had a press release: APA Corporation Provides Update on Block 58 Appraisal and Exploration Activities. |
| CCL | 2.79% | CARNIVAL CORP's (NYSE:CCL) shares rose 2.79% to $9.58. Shareholders saw the stock price going 31.01% lower is the past 6 months. |
| TPR | 2.74% | TAPESTRY INC's (NYSE:TPR) stock price is advancing with 2.74% to a price of $37.48. |
To see the full list of top gainers you can use our top gainers screener.
Losers
| Ticker | Change | Comment |
|---|---|---|
| LUMN | -3.17% | LUMEN TECHNOLOGIES INC's (NYSE:LUMN) shares fell 3.17% to $5.34. The stock is trading 24.8% lower than a month ago. |
| BR | -3.05% | BROADRIDGE FINANCIAL SOLUTIO's (NYSE:BR) shares fell 3.05% to $142.03 during Tuesday's session. |
| ILMN | -3.0% | ILLUMINA INC's (NASDAQ:ILMN) stock price decreased by 3.0% to $210.4. In the last year the stock lost 37.54%. |
| PYPL | -2.79% | PAYPAL HOLDINGS INC's (NASDAQ:PYPL) stock price decreased by 2.79% to $77.7. A press release (Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Olo, Centessa, PayPal, and Opendoor and Encourages Investors to Contact the Firm) was released two days ago. |
| JKHY | -2.53% | JACK HENRY & ASSOCIATES INC's (NASDAQ:JKHY) shares fell 2.53% to $184.03. In the last year the stock gained 22.58%. |
| TRMB | -2.51% | TRIMBLE INC's (NASDAQ:TRMB) stock price decreased by 2.51% to $56.02. In the last year the share price dropped with 31.41%. |
| SNPS | -2.33% | SYNOPSYS INC's (NASDAQ:SNPS) stock price is declining with 2.33% to a price of $321.45. SYNOPSYS INC is releasing earnings today. |
| ULTA | -2.32% | ULTA BEAUTY INC's (NASDAQ:ULTA) shares fell 2.32% to $446.61. NASDAQ:ULTA is releasing earnings today. In the last year the share price increased with 20.7%. |
| NWL | -2.21% | NEWELL BRANDS INC's (NASDAQ:NWL) shares fell 2.21% to $12.83. The stock is trading 25.11% lower than 3 months ago. |
| HRL | -2.18% | HORMEL FOODS CORP's (NYSE:HRL) shares fell 2.18% to $48.04 during Tuesday's session. NYSE:HRL is releasing earnings today. |
For the full top loser list go to our top losers screener.
ILLUMINA INC
NASDAQ:ILMN (4/24/2024, 7:09:32 PM)
After market: 125.95 +3.08 (+2.51%)122.87
-1.59 (-1.28%)
ILMN News
Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.
6 days ago - Zacks Investment ResearchCan Illumina (ILMN) Keep the Earnings Surprise Streak Alive?Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
9 days ago - InvestorPlaceThe Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s LeavingInvesting with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her.
9 days ago - Market News VideoNotable Tuesday Option Activity: META, ILMN, COST9 days ago - Market News VideoIllumina Becomes Oversold (ILMN)9 days ago - Market News VideoNasdaq 100 Movers: TSLA, AMD
10 days ago - ChartmillTop S&P500 movers in Monday's sessionCurious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
10 days ago - ChartmillWhat's going on in today's session: S&P500 moversWondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
10 days ago - ChartmillWondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.Gapping S&P500 stocks in Monday's session
13 days ago - Illumina, Inc.Illumina's planned divestment of GRAIL approved by the European Commission/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its...
13 days ago - Yahoo FinanceUPDATE 1-EU approves Illumina's plan to divest cancer test maker GrailU.S. gene sequencing company Illumina's plan to divest cancer diagnostic test maker Grail has received the green light from EU antitrust regulators which blocked the deal two years ago. Illumina jumped the gun in 2021 when it completed the $7.1-billion acquisition before first securing EU regulatory approval. That prompted the European Commission, which acts as the competition enforcer in the 27-country European Union, to order the company to keep Grail separate from Illumina.
15 days ago - Yahoo FinanceUPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeedIllumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the gene sequencing company and be succeeded by former Summit Therapeutics' executive Ankur Dhingra. Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 and will serve as an adviser till June 30, the company said. Prior to Summit, Dhingra was the CFO at medical test maker CareDx.
